BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35783387)

  • 1. Fungal Endophthalmitis in a Case of Rhino-Orbito-Cerebral Mucormycosis: Successfully Treated With Amphotericin B Colloidal Dispersion.
    Zhao Y; Tian W; Yang J; Li X; Lu H; Yu N; Zhang P; Liu C; Chen P; Lei G; Liu Y
    Front Microbiol; 2022; 13():910419. PubMed ID: 35783387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination antifungal therapy without craniotomy in an immunocompromised patient with rhino-orbito-cerebral mucormycosis: A case report.
    Salehi M; Shahi F; Rizvi FS; Ghaderkhani S; Zainaldain H; Khodavaisy S; Jamali-Moghaddam SR; Dehghan Manshadi SA; Rezahosseini O
    Caspian J Intern Med; 2020; 11(2):227-230. PubMed ID: 32509254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unilateral rhino-orbital-cerebral mucormycosis with contralateral endogenous fungal endophthalmitis.
    Ho HC; Liew OH; Teh SS; Hanizasurana H; Ibrahim M; Shatriah I
    Clin Ophthalmol; 2015; 9():553-6. PubMed ID: 25848206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.
    Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q
    BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhino-orbital-cerebral mucormycosis (ROCM) and associated cerebritis treated with adjuvant retrobulbar amphotericin B.
    Safi M; Ang MJ; Patel P; Silkiss RZ
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100771. PubMed ID: 32551404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive Protein Kinetics During In-Patient Treatment of COVID-19-Associated Rhino-Orbito-Cerebral Mucormycosis: A Retrospective Cohort Study in a Tertiary Hospital in Central India.
    B H S; Bidkar V; Prathipati K; Dabhekar S; Selvaraj K; G D
    Cureus; 2024 Apr; 16(4):e59007. PubMed ID: 38800245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing mucormycosis in diabetic patients: A case report with critical review of the literature.
    Beiglboeck FM; Theofilou NE; Fuchs MD; Wiesli MG; Leiggener C; Igelbrink S; Augello M
    Oral Dis; 2022 Apr; 28(3):568-576. PubMed ID: 33583133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
    Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality and its determinants after an outbreak of post COVID-19 associated rhino-orbito-cerebral mucormycosis in Central India.
    Nagarkar NM; Sahu V; Arora R; Pathak M; Shambharkar MS; Naveen P
    Int Ophthalmol; 2023 Jul; 43(7):2363-2370. PubMed ID: 36645635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study.
    Manesh A; Devasagayam E; Bhanuprasad K; Varghese L; Kurien R; Cherian LM; Dayanand D; George MM; Kumar SS; Karthik R; Vanjare H; Peter J; Michael JS; Thomas M; Mathew BS; Samuel P; Peerawaranun P; Mukaka M; Rupa V; Varghese GM
    Clin Microbiol Infect; 2023 Oct; 29(10):1298-1305. PubMed ID: 37348653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhino-orbito-cerebral mucormycosis: report of two cases and review of the literature.
    Haliloglu NU; Yesilirmak Z; Erden A; Erden I
    Dentomaxillofac Radiol; 2008 Mar; 37(3):161-6. PubMed ID: 18316508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
    Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S
    J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features, diagnosis, and outcomes of rhino-orbito-cerebral mucormycosis- A retrospective analysis.
    Abdollahi A; Shokohi T; Amirrajab N; Poormosa R; Kasiri AM; Motahari SJ; Ghoreyshi SM; Madani SA; Nikkhah M; Ghasemi M; Vahedi Larijani L; Didehdar M; Seifi Z; Gholinejad N; Ilkit M
    Curr Med Mycol; 2016 Dec; 2(4):15-23. PubMed ID: 28959791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhino-orbital and rhino-orbito-cerebral mucormycosis.
    Talmi YP; Goldschmied-Reouven A; Bakon M; Barshack I; Wolf M; Horowitz Z; Berkowicz M; Keller N; Kronenberg J
    Otolaryngol Head Neck Surg; 2002 Jul; 127(1):22-31. PubMed ID: 12161726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of Itraconazole in Combination with Liposomal Amphotericin B in Rhizopus oryzae Associated Mucormycosis-An Exploratory Study.
    Dandu H; Kumar N; Kumar N; Malhotra HS; Prabhu V; Bharti VR; Gupta P; Yadav G; Verma V
    Mycopathologia; 2024 Jun; 189(4):54. PubMed ID: 38865003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study.
    Cag Y; Erdem H; Gunduz M; Komur S; Ankarali H; Ural S; Tasbakan M; Tattevin P; Tombak A; Ozturk-Engin D; Tartar AS; Batirel A; Tekin R; Duygu F; Caskurlu H; Kurtaran B; Durdu B; Haciseyitoglu D; Rello J;
    Eur J Intern Med; 2022 Jun; 100():56-61. PubMed ID: 35304041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
    Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
    Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhino-Orbito-Cerebral Mucormycosis: An Audit.
    Saravanam PK; Thattarakkal VR; Arun A
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2686-2692. PubMed ID: 36452555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory rhino-orbito-cerebral mucormycosis treated with intraconal amphotericin B.
    GuimarĂ£es JA; Moura FC
    Arq Bras Oftalmol; 2022; 85(1):77-81. PubMed ID: 34468552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucormycosis in post-covid patients: An epidemic in pandemic.
    Kesarwani V; Kumar A; Kesarwaani S; Kesarwani D
    J Family Med Prim Care; 2022 Jun; 11(6):3368-3371. PubMed ID: 36119254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.